Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_assertion type Assertion NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_head.
- NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_assertion description "[Moreover, since defects in the pathway for PCD can render neoplastic cells resistant to the cytotoxic effects of chemotherapeutic drugs and radiation, investigations of the molecular biology of CLL may also prove informative for gaining a better understanding of drug- and radiation-resistance mechanisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_provenance.
- NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_assertion evidence source_evidence_literature NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_provenance.
- NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_assertion SIO_000772 9482522 NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_provenance.
- NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_assertion wasDerivedFrom befree-20140225 NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_provenance.
- NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_assertion wasGeneratedBy ECO_0000203 NP452055.RAw3WjUukgubomxoiVFKZLTmUT5jA5sgfBnbE8vo4w0kA130_provenance.